Medical Marijuana And Cancer Research

A report from Salerno, Italy suggests that naturallycancer.”
occurring compounds in cannabis (medical marijuana)A 2008 review in the journal Cancer Research
possess anti-tumor properties. This information allowsreported that the administration of cannabinoids halts
for a new approach to treating cancer according tothe spread of a wide range of cancers, including brain
the review that was published in the February issuecancer, prostate cancer, breast cancer, lung cancer,
of the journal, Best Practice & Research: Clinicalskin cancer, pancreatic cancer, and lymphoma. This is
Endocrinology & Metabolism.great news for those who are suffering from the
According to the investigators at the University ofdifferent forms of cancer.
Salerno, cannabinoids (one of the compounds foundTo date, only one clinical trial assessing the use of
in medical marijuana) limit cancer cell proliferation andcannabinoids as anti-cancer agents has been
induce tumor-selective cell death.conducted. That trial reported that THC
The authors of the scientific review concluded that,administration decreases recurrent glioblastoma
cannabinoids inhibit “tumor growth and migration,multiforme (GBM) tumor growth in patients afflicted
angiogenesis (the formation of new blood vessels towith the disease.
cancerous tumors), [and] metastasis (the transfer ofAs more and more states create laws allowing for
malignant cells from one site to another).” Theythe use of medical marijuana we expect that the
are also quoted as stating that, “Emergingmedical community will also come along side and do
evidence suggests that agonists of cannabinoideven more scientific research into the qualities and
receptors … may offer a novel strategy to treatbenefits of medical marijuana.